Injectable formulations of poly(lactic acid) and its copolymers in clinical use
- PMID: 27423636
- DOI: 10.1016/j.addr.2016.07.002
Injectable formulations of poly(lactic acid) and its copolymers in clinical use
Abstract
Poly(lactic acid) and its copolymers have revolutionized the field of drug delivery due to their excellent biocompatibility and tunable physico-chemical properties. These copolymers have served the healthcare sector by contributing many products to combat various diseases and for biomedical applications. This article provides a comprehensive overview of clinically used products of poly(lactic acid) and its copolymers. Multi-dimension information covering product approval, formulation aspects and clinical status is described to provide a panoramic overview of each product. Moreover, leading patented technologies and various clinical trials on these products for different applications are included. This review focuses on marketed injectable formulations of PLA and its copolymers.
Keywords: Injectable depot; Microspheres; PLA clinical products; PLA copolymers; Poly(lactic acid).
Copyright © 2016 Elsevier B.V. All rights reserved.
Similar articles
-
Polylactic acid (PLA) controlled delivery carriers for biomedical applications.Adv Drug Deliv Rev. 2016 Dec 15;107:163-175. doi: 10.1016/j.addr.2016.06.018. Epub 2016 Jul 15. Adv Drug Deliv Rev. 2016. PMID: 27426411 Review.
-
Drug Delivery and Cosmeceutical Applications of Poly- Lactic Acid Based Novel Constructs - A Review.Curr Drug Metab. 2017;18(10):914-925. doi: 10.2174/1389200218666170919170335. Curr Drug Metab. 2017. PMID: 28933269 Review.
-
Design and in vitro assessment of L-lactic acid-based copolymers as prodrug and carrier for intravitreal sustained L-lactate release to reverse retinal arteriolar occlusions.Eur J Pharm Sci. 2013 May 13;49(2):233-40. doi: 10.1016/j.ejps.2013.02.021. Epub 2013 Mar 14. Eur J Pharm Sci. 2013. PMID: 23500039
-
Poly(D,L-lactide-co-ethyl ethylene phosphate)s as new drug carriers.J Control Release. 2003 Sep 19;92(1-2):39-48. doi: 10.1016/s0168-3659(03)00294-3. J Control Release. 2003. PMID: 14499184
-
Facile Layer-by-Layer Self-Assembly toward Enantiomeric Poly(lactide) Stereocomplex Coated Magnetite Nanocarrier for Highly Tunable Drug Deliveries.ACS Appl Mater Interfaces. 2016 Jan 27;8(3):1842-53. doi: 10.1021/acsami.5b09822. Epub 2016 Jan 12. ACS Appl Mater Interfaces. 2016. PMID: 26717323
Cited by
-
Biodegradable polymers for modern vaccine development.J Ind Eng Chem. 2019 Sep 25;77:12-24. doi: 10.1016/j.jiec.2019.04.044. Epub 2019 Apr 28. J Ind Eng Chem. 2019. PMID: 32288512 Free PMC article. Review.
-
Timeline of Translational Formulation Technologies for Cancer Therapy: Successes, Failures, and Lessons Learned Therefrom.Pharmaceutics. 2020 Oct 28;12(11):1028. doi: 10.3390/pharmaceutics12111028. Pharmaceutics. 2020. PMID: 33126622 Free PMC article. Review.
-
Preparation of PLGA Microspheres Using the Non-Toxic Glycofurol as Polymer Solvent by a Modified Phase Inversion Methodology.Polymers (Basel). 2024 Feb 4;16(3):434. doi: 10.3390/polym16030434. Polymers (Basel). 2024. PMID: 38337323 Free PMC article.
-
Poly(d,l-lactide-co-glycolide) Surface-Anchored Biotin-Loaded Irinotecan Nanoparticles for Active Targeting of Colon Cancer.ACS Omega. 2024 Jan 10;9(3):3807-3826. doi: 10.1021/acsomega.3c07833. eCollection 2024 Jan 23. ACS Omega. 2024. PMID: 38284072 Free PMC article.
-
Case - Leuprolide acetate-induced necrotic skin ulceration.Can Urol Assoc J. 2023 Mar;17(3):E92-E94. doi: 10.5489/cuaj.8112. Can Urol Assoc J. 2023. PMID: 36473470 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources